Zobrazeno 1 - 5
of 5
pro vyhledávání: '"André Ahr"'
Publikováno v:
Geburtshilfe und Frauenheilkunde. 82:1378-1386
Introduction On 1 January 2020 the screening programme for the prevention of cervical cancer in women from the age of 35 years of the Statutory Health Insurance (GKV) in Germany changed from an annual cytology examination to cytological and HPV co-te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::878d10f2707fb8de3bc56ecc11ec82a2
https://doi.org/10.1055/a-1886-3311
https://doi.org/10.1055/a-1886-3311
Publikováno v:
Cancer Cytopathology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8cf7c3ebacded902c459dcb351af75cf
https://doi.org/10.1002/cncy.22695
https://doi.org/10.1002/cncy.22695
Autor:
Uwe J. Göhring, Veronika Weisner, André Ahr, Anton Scharl, Werner Neuhaus, Gerd Crombach, John A. Holt
Publikováno v:
Journal of the Society for Gynecologic Investigation. 2:653-659
We sought to determine whether the immunohistochemical detection of epidermal growth factor receptor (EGF-R) in primary cancer tissues is of prognostic significance in patients with breast carcinoma. Paraffin-embedded tissues from 244 study subjects
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8cfac33c409c886c767cc133624cd14b
https://doi.org/10.1177/107155769500200412
https://doi.org/10.1177/107155769500200412
Publikováno v:
The Lancet. 360:174
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6a1fff54de77aa4da263ddd8404f564
https://doi.org/10.1016/s0140-6736(02)09398-4
https://doi.org/10.1016/s0140-6736(02)09398-4
Autor:
Thomas Karn, Lajos Pusztai, Uwe Holtrich, Takayuki Iwamoto, Christine Y Shiang, Marcus Schmidt, Volkmar Müller, Christine Solbach, Regine Gaetje, Lars Hanker, Andre Ahr, Cornelia Liedtke, Eugen Ruckhäberle, Manfred Kaufmann, Achim Rody
Publikováno v:
PLoS ONE, Vol 6, Iss 12, p e28403 (2011)
BackgroundCurrent prognostic gene signatures for breast cancer mainly reflect proliferation status and have limited value in triple-negative (TNBC) cancers. The identification of prognostic signatures from TNBC cohorts was limited in the past due to
Externí odkaz:
https://doaj.org/article/11e2ff571171401c9ba3fb6bd4809bd3